Каzakhstan is among the world’s 27 high-burden countries for multidrug-resistant tuberculosis (MDR-TB). Almost one in five new TB cases are MDR-TB, and half of all returning patients who had previously been treated for TB have since contracted MDR-TB.
In an effort to help reduce its contribution to climate change resulting from greenhouse gas buildup, Kazakhstan launched a greenhouse gas emissions trading program last year, which requires high-emitting businesses to reduce their emissions each year. However, many companies do not yet have the tools to comply with the requirements and the know-how to reduce their emissions footprint over time.
July 2014—For victims of trafficking, Kazakhstan serves as a destination, transit and source country. Kazakhstan remains attractive as a destination for citizens from less economically stable countries of Central Asia. For those being trafficked from Kazakhstan, the main destination countries are Russia, the United Arab Emirates and Turkey.
July 2014—Because “monotowns”—towns dominated by a single factory or industry—are vulnerable to economic disruptions, Kazakhstan is working to diversify its local economies.
April 2014—Most tuberculosis (TB) patients in Kazakhstan, including non-infectious TB patients, are hospitalized from the time of their initial diagnosis to the end of the intensive phase of treatment. This ranges from two to four months for regular TB, and six to 12 months for multidrug-resistant TB (MDR-TB) cases.
Last updated: October 26, 2016